Clinical Trials Logo
  1. Home
  2. Ischemic Stroke
  3. NCT05734352
  4. Details
NCT05734352 Clinical Trial

Patient Experiences on the Stroke Unit

Ischemic Stroke Clinical Trial

— BIC4CVAPREMS  

Official title:
Patient Experiences of the CVA Care Program on the Stroke Unit

Clinical Trial Details — Status: Enrolling by invitation

Administrative data
NCT number NCT05734352
Other study ID # BIC4STROKEPREMS
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date February 21, 2023
Est. completion date September 30, 2024

Study information
Verified date February 2024
Source KU Leuven
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In this study we want to develop and validate a PREM for patient with ischemic stroke.

Description:

Patient Reported Experience Measures (PREMs) assess patient's perception of health care. Currently, there is no suitable PREM tool for patients with ischemic stroke. Therefore, we aim to develop and validate a PREM for this patient population. This PREM will be validated in a multicentre study, in 10 Flemish hospitals. We want to investigate the feasibility of our new questionnaire, as well as the usefulness. In addition we well analyse the results of the questionnaires and use this information to improve the quality of the care program for stroke patients.

Recruitment information / eligibility
Status Enrolling by invitation
Enrollment 500
Est. completion date September 30, 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - > 18 years - ischemic stroke - stayed at least one day at the stroke unit Exclusion Criteria: - not able to read the questionnaire - not able to answer question orally - are not proficient in the dutch language

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Questionnaire
Completion of the patient reported experience measurements (PREMs) questionnaire

Locations
Country Name City State
Belgium KU Leuven Leuven Flemish Brabant

Sponsors (1)
Lead Sponsor Collaborator
KU Leuven

Country where clinical trial is conducted

Belgium, 

Outcome
Type Measure Description Time frame Safety issue
Primary Validation of a new Patient Reported Experience Measurements (PREMs) for stroke patients Validation of a questionnaire which was developed based on literature and consensus meeting 6-months
Secondary Patient experiences How do patients experience their received care when they are admitted to the stroke unit/neurology department 6-months
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Completed NCT03281590 - Stroke and Cerebrovascular Diseases Registry
Recruiting NCT05518305 - Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT03728738 - Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke Phase 3
Terminated NCT03396419 - IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
Recruiting NCT05065216 - Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) Phase 2/Phase 3
Recruiting NCT04897334 - Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke N/A
Not yet recruiting NCT06462599 - Osteopontin Gene Polymorphism in Stroke Patients in Egypt
Not yet recruiting NCT06032819 - Differentiating Between Brain Hemorrhage and Contrast
Not yet recruiting NCT06026696 - Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
Recruiting NCT02910180 - Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
Completed NCT03554642 - Walkbot Robotic Training for Improvement in Gait Phase 3
Completed NCT02922452 - A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects Phase 1
Withdrawn NCT01866189 - Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke N/A
Recruiting NCT03041753 - Reperfusion Injury After Stroke Study N/A
Completed NCT02549846 - AdminiStration of Statin On Acute Ischemic stRoke patienT Trial Phase 4
Completed NCT02610803 - Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke N/A
Completed NCT01678534 - Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial Phase 2